Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Dynavax Technologies PE Ratio 2006-2019 | DVAX

Current and historical p/e ratio for Dynavax Technologies (DVAX) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Dynavax Technologies PE ratio as of November 20, 2019 is 0.00.
  
Dynavax Technologies PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-11-20 5.22 0.00
2019-09-30 3.58 $-2.41 0.00
2019-06-30 3.99 $-2.57 0.00
2019-03-31 7.31 $-2.54 0.00
2018-12-31 9.15 $-2.55 0.00
2018-09-30 12.40 $-2.36 0.00
2018-06-30 15.25 $-2.09 0.00
2018-03-31 19.85 $-1.87 0.00
2017-12-31 18.70 $-1.84 0.00
2017-09-30 21.50 $-1.95 0.00
2017-06-30 9.65 $-2.47 0.00
2017-03-31 5.95 $-2.81 0.00
2016-12-31 3.95 $-2.91 0.00
2016-09-30 10.49 $-3.05 0.00
2016-06-30 14.58 $-2.97 0.00
2016-03-31 19.24 $-3.02 0.00
2015-12-31 24.16 $-3.29 0.00
2015-09-30 24.54 $-3.44 0.00
2015-06-30 23.43 $-3.72 0.00
2015-03-31 22.43 $-2.02 0.00
2014-12-31 16.86 $-1.55 0.00
2014-09-30 14.30 $-1.60 0.00
2014-06-30 16.00 $-1.40 0.00
2014-03-31 18.08 $-3.20 0.00
2013-12-31 19.60 $-3.80 0.00
2013-09-30 11.90 $-4.00 0.00
2013-06-30 11.00 $-4.10 0.00
2013-03-31 22.20 $-4.10 0.00
2012-12-31 28.50 $-4.10 0.00
2012-09-30 47.60 $-3.30 0.00
2012-06-30 43.20 $-3.50 0.00
2012-03-31 50.30 $-3.50 0.00
2011-12-31 33.20 $-4.00 0.00
2011-09-30 18.60 $-5.10 0.00
2011-06-30 27.50 $-4.50 0.00
2011-03-31 27.60 $-7.00 0.00
2010-12-31 32.00 $-7.10 0.00
2010-09-30 18.30 $-13.00 0.00
2010-06-30 18.60 $-14.80 0.00
2010-03-31 13.00 $-10.40 0.00
2009-12-31 14.20 $-7.40 0.00
2009-09-30 18.20 $0.70 26.00
2009-06-30 12.90 $1.70 7.59
2009-03-31 6.40 $-0.80 0.00
2008-12-31 8.40 $-5.20 0.00
2008-09-30 14.20 $-9.00 0.00
2008-06-30 14.60 $-11.90 0.00
2008-03-31 19.60 $-14.90 0.00
2007-12-31 51.10 $-15.10 0.00
2007-09-30 42.90 $-16.50 0.00
2007-06-30 41.50 $-16.20 0.00
2007-03-31 54.40 $-16.70 0.00
2006-12-31 91.80 $-16.10 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.493B $0.008B
Dynavax Technologies discovers, develops, and intends to commercialize innovative products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using versatile, proprietary approaches that alter immune system responses in highly specific ways. Dynavax's clinical development programs are based on immunostimulatory sequences which are short DNA sequences that enhance the ability of the immune system to fight disease and control chronic inflammation.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.118B 15.10
CSL (CSLLY) Australia $83.969B 0.00
Gilead Sciences (GILD) United States $81.336B 10.08
Celgene (CELG) United States $77.805B 11.11
Vertex Pharmaceuticals (VRTX) United States $54.001B 55.12
Biogen (BIIB) United States $50.996B 8.75
Illumina (ILMN) United States $45.080B 49.46
Regeneron Pharmaceuticals (REGN) United States $37.351B 16.35
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.893B 11.80
Seattle Genetics (SGEN) United States $19.834B 0.00
Incyte (INCY) United States $18.845B 43.74
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.938B 0.00
Genmab (GNMSF) Denmark $14.056B 62.08
BioMarin Pharmaceutical (BMRN) United States $13.502B 0.00
Exact Sciences (EXAS) United States $10.667B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
Alnylam Pharmaceuticals (ALNY) United States $10.338B 0.00
Galapagos (GLPG) Belgium $10.332B 26.62
BeiGene (BGNE) Cayman Islands $9.307B 0.00
QIAGEN (QGEN) Netherlands $9.257B 30.18
Amarin (AMRN) Ireland $8.073B 0.00
Bio-Techne Corp (TECH) United States $8.058B 53.93
Guardant Health (GH) United States $7.399B 0.00
Sarepta Therapeutics (SRPT) United States $7.298B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.942B 0.00
Moderna (MRNA) United States $6.482B 0.00
Reata Pharmaceuticals (RETA) United States $6.275B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.755B 14.63
ARGENX SE-ADR (ARGX) Netherlands $5.392B 0.00
Exelixis (EXEL) United States $4.931B 13.87
Medicines (MDCO) United States $4.676B 0.00
China Biologic Products (CBPO) China $4.605B 25.94
Ascendis Pharma (ASND) Denmark $4.508B 0.00
Repligen (RGEN) United States $4.499B 81.54
Spark Therapeutics (ONCE) United States $4.282B 0.00
Bluebird Bio (BLUE) United States $4.150B 0.00
Adaptive Biotechnologies (ADPT) United States $3.748B 0.00
Blueprint Medicines (BPMC) United States $3.668B 0.00
Mirati Therapeutics (MRTX) United States $3.653B 0.00
MorphoSys AG (MOR) Germany $3.563B 0.00
Immunomedics (IMMU) United States $3.442B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.231B 0.00
Alkermes (ALKS) Ireland $3.176B 0.00
Genmab (GMAB) Denmark $2.923B 6.02
Emergent Biosolutions (EBS) United States $2.806B 27.87
Halozyme Therapeutics (HALO) United States $2.767B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.717B 0.00
NeoGenomics (NEO) United States $2.532B 134.72
MyoKardia (MYOK) United States $2.497B 0.00
Amicus Therapeutics (FOLD) United States $2.441B 0.00
UniQure (QURE) Netherlands $2.314B 0.00
Arena Pharmaceuticals (ARNA) United States $2.266B 5.27
Acceleron Pharma (XLRN) United States $2.255B 0.00
Zai Lab (ZLAB) China $2.251B 0.00
RA PHARMCTL INC (RARX) United States $2.202B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.121B 0.00
Cambrex (CBM) United States $2.017B 25.46
Myriad Genetics (MYGN) United States $1.841B 27.20
Ligand Pharmaceuticals (LGND) United States $1.818B 34.97
Insmed (INSM) United States $1.797B 0.00
Akcea Therapeutics (AKCA) United States $1.762B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.514B 0.00
Zymeworks (ZYME) Canada $1.465B 0.00
Denali Therapeutics (DNLI) United States $1.464B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.464B 0.00
Epizyme (EPZM) United States $1.404B 0.00
REGENXBIO (RGNX) United States $1.377B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.350B 0.00
Coherus BioSciences (CHRS) United States $1.345B 0.00
Innoviva (INVA) United States $1.267B 3.73
Editas Medicine (EDIT) United States $1.188B 0.00
Zealand Pharma (ZLDPF) Denmark $1.185B 0.00
Zealand Pharma (ZEAL) Denmark $1.161B 0.00
Alector (ALEC) United States $1.094B 0.00
Sangamo Therapeutics (SGMO) United States $1.083B 0.00
Fate Therapeutics (FATE) United States $1.081B 0.00
Arvinas (ARVN) United States $1.048B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.997B 0.00
WAVE Life Sciences (WVE) Singapore $0.980B 0.00
Principia Biopharma (PRNB) United States $0.954B 0.00
Athenex (ATNX) United States $0.887B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.877B 0.00
Codexis (CDXS) United States $0.865B 0.00
Anika Therapeutics (ANIK) United States $0.857B 27.82
Cara Therapeutics (CARA) United States $0.847B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.830B 6.98
Vericel (VCEL) United States $0.824B 307.17
ZIOPHARM Oncology Inc (ZIOP) United States $0.816B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.791B 0.00
Pharming Group (PHGUF) Netherlands $0.753B 0.00
Heska (HSKA) United States $0.721B 184.16
Revance Therapeutics (RVNC) United States $0.719B 0.00
Twist Bioscience (TWST) United States $0.691B 0.00
ANI Pharmaceuticals (ANIP) United States $0.678B 11.56
DBV Technologies S.A (DBVT) France $0.671B 0.00
Intellia Therapeutics (NTLA) United States $0.665B 0.00
MiMedx (MDXG) United States $0.653B 0.00
Precision BioSciences (DTIL) United States $0.643B 0.00
Agenus (AGEN) United States $0.604B 0.00
Mesoblast (MESO) Australia $0.601B 0.00
Adverum Biotechnologies (ADVM) United States $0.590B 0.00
GENFIT S.A (GNFT) France $0.580B 0.00
Cellectis S.A (CLLS) France $0.565B 0.00
Retrophin (RTRX) United States $0.559B 0.00
BioDelivery Sciences (BDSI) United States $0.545B 0.00
UROGEN PHARMA (URGN) United States $0.545B 0.00
Kadmon Holdings (KDMN) United States $0.536B 0.00
Stemline Therapeutics (STML) United States $0.525B 0.00
Cytokineticsorporated (CYTK) United States $0.496B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.493B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.479B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.479B 0.00
Intra-Cellular Therapies (ITCI) United States $0.478B 0.00
AC Immune SA (ACIU) Switzerland $0.476B 11.02
Sinovac Biotech (SVA) China $0.460B 0.00
PHARMA MAR SA (PHMMF) Spain $0.440B 0.00
Prothena (PRTA) Ireland $0.409B 0.00
Clovis Oncology (CLVS) United States $0.387B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.375B 2.60
Merus (MRUS) Netherlands $0.366B 0.00
Bellus Health (BLU) Canada $0.364B 0.00
Cellular Biomedicine (CBMG) United States $0.349B 0.00
PDL BioPharma (PDLI) United States $0.344B 8.60
Arcus Biosciences (RCUS) United States $0.336B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.326B 0.00
Starpharma Holdings (SPHRY) Australia $0.318B 0.00
Puma Biotechnology (PBYI) United States $0.305B 0.00
AnaptysBio (ANAB) United States $0.301B 0.00
Compugen (CGEN) Israel $0.293B 0.00
Avid Bioservices (CDMO) United States $0.291B 0.00
Kindred Biosciences (KIN) United States $0.288B 0.00
Protagonist Therapeutics (PTGX) United States $0.278B 0.00
Pfenex (PFNX) United States $0.270B 0.00
Sutro Biopharma (STRO) United States $0.263B 0.00
Cel-Sci (CVM) United States $0.261B 0.00
Gritstone Oncology (GRTS) United States $0.261B 0.00
Seres Therapeutics (MCRB) United States $0.256B 0.00
Geron (GERN) United States $0.254B 0.00
Biofrontera AG (BFRA) Germany $0.248B 370.07
MannKind (MNKD) United States $0.248B 0.00
Theratechnologies (THTX) Canada $0.242B 0.00
ADMA Biologics Inc (ADMA) United States $0.241B 0.00
Kamada (KMDA) Israel $0.239B 6.98
OSMOTICA PHARM (OSMT) United States $0.238B 0.00
CytomX Therapeutics (CTMX) United States $0.235B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.232B 0.00
Inovio Pharmaceuticals (INO) United States $0.228B 0.00
XOMA (XOMA) United States $0.226B 0.00
Albireo Pharma (ALBO) United States $0.225B 0.00
Athersys (ATHX) United States $0.218B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.215B 0.00
Scholar Rock Holding (SRRK) United States $0.214B 0.00
POXEL SA FRANCE (PXXLF) France $0.213B 0.00
Cue Biopharma (CUE) United States $0.209B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.208B 0.00
Syros Pharmaceuticals (SYRS) United States $0.208B 0.00
ChromaDex (CDXC) United States $0.197B 0.00
Sorrento Therapeutics (SRNE) United States $0.194B 0.00
Exicure (XCUR) United States $0.187B 0.00
Affimed (AFMD) Germany $0.185B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.184B 0.00
Spero Therapeutics (SPRO) United States $0.181B 0.00
Palatin Technologies (PTN) United States $0.180B 4.91
CorMedix Inc (CRMD) United States $0.173B 0.00
Dyadic (DYAI) United States $0.171B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.168B 0.00
Arsanis (XFOR) United States $0.165B 0.00
Senesco Technologies (ELOX) United States $0.164B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.157B 0.00
Alcobra (ARCT) United States $0.147B 0.00
Nicox SA (NICXF) France $0.141B 0.00
Cerecor (CERC) United States $0.137B 0.00
Enzo Biochem (ENZ) United States $0.136B 0.00
Fortress Biotech (FBIO) United States $0.133B 0.00
Emmaus Life Sciences (EMMA) United States $0.133B 0.00
Northwest Biotherapeutics (NWBO) United States $0.131B 0.00
Mersana Therapeutics (MRSN) United States $0.130B 0.00
BioTime (LCTX) United States $0.130B 6.65
Ophthotech (ISEE) United States $0.125B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.121B 0.00
SESEN BIO, INC (SESN) United States $0.119B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.117B 0.00
Five Prime Therapeutics (FPRX) United States $0.116B 0.00
Windtree Therapeutics (WINT) United States $0.116B 0.00
Abeona Therapeutics (ABEO) United States $0.114B 0.00
NantKwest (NK) United States $0.112B 0.00
Aptinyx (APTX) United States $0.106B 0.00
OvaScience (MLND) United States $0.106B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.106B 0.00
VBI Vaccines (VBIV) United States $0.106B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.104B 0.00
Novavax (NVAX) United States $0.102B 0.00
Menlo Therapeutics (MNLO) United States $0.095B 0.00
PHASEBIO PHARMA (PHAS) United States $0.093B 0.00
Celyad SA (CYAD) Belgium $0.090B 0.00
Antibe Therapeutics (ATBPF) Canada $0.090B 0.00
Aduro Biotech (ADRO) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.084B 0.00
Arbutus Biopharma (ABUS) Canada $0.084B 0.00
VTv Therapeutics (VTVT) United States $0.083B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.080B 0.00
Strongbridge Biopharma (SBBP) United States $0.080B 2.13
Acorda Therapeutics (ACOR) United States $0.078B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
ARAVIVE, INC (ARAV) United States $0.073B 0.00
Vaccinex (VCNX) United States $0.068B 0.00
Selecta Biosciences (SELB) United States $0.068B 0.00
Prima BioMed (IMMP) Australia $0.067B 0.00
Liquidia Technologies (LQDA) United States $0.064B 0.00
Verastem (VSTM) United States $0.064B 0.00
Synlogic (SYBX) United States $0.063B 0.00
Trevena (TRVN) United States $0.063B 0.00
Catalyst Biosciences (CBIO) United States $0.063B 0.00
Checkpoint Therapeutics (CKPT) United States $0.062B 0.00
Idera Pharmaceuticals (IDRA) United States $0.061B 0.00
Organovo Holdings (ONVO) United States $0.060B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.059B 0.00
NewLink Genetics (NLNK) United States $0.058B 0.00
Proteostasis Therapeutics (PTI) United States $0.055B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.053B 0.00
Orgenesis (ORGS) United States $0.053B 3.39
China Health Industries Holdings (CHHE) China $0.052B 15.78
Applied Genetic Technologies (AGTC) United States $0.051B 0.00
Pluristem Therapeutics (PSTI) Israel $0.050B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.050B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
Curis (CRIS) United States $0.046B 0.00
AIT Therapeutics (XAIR) United States $0.045B 0.00
DiaMedica Therapeutics (DMAC) United States $0.045B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.044B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.043B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Clearside Biomedical (CLSD) United States $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Protalix BioTherapeutics (PLX) Israel $0.038B 0.00
Evogene (EVGN) Israel $0.038B 0.00
Stellar Biotechnologies (EDSA) Canada $0.037B 0.00
Celldex Therapeutics (CLDX) United States $0.034B 0.00
Celsion (CLSN) United States $0.032B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.031B 0.00
Oncobiologics (OTLK) United States $0.030B 0.00
Caladrius Biosciences (CLBS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.56
VIVUS (VVUS) United States $0.029B 0.00
Entera Bio (ENTX) Israel $0.029B 0.00
Bionano Genomics (BNGO) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.028B 0.00
BioCardia (BCDA) United States $0.027B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.024B 0.00
Apricus Biosciences (SEEL) United States $0.023B 0.00
Unum Therapeutics (UMRX) United States $0.023B 0.00
Novogen (KZIA) Australia $0.022B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.021B 0.00
Signal Genetics (MGEN) United States $0.020B 0.00
Soligenix (SNGX) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Aytu Bioscience (AYTU) United States $0.016B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
VistaGen Therapeutics (VTGN) United States $0.015B 0.00
Prana Biotechnology (ATHE) Australia $0.015B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Cesca Therapeutics (THMO) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Advaxis (ADXS) United States $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.004B 0.00
IBio (IBIO) United States $0.003B 0.00
Neuralstem (SNCA) United States $0.002B 0.00